Dare Bioscience Inc (DARE) Stock Analysis

Dare Bioscience Inc (DARE) is a publicly traded company in the HEALTHCARE sector. It trades at $2.14, carries a market capitalization of $32.81M. This page summarizes the public market data, fundamentals, and frequently asked questions for DARE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.14
• Market Cap: $32.81M
• EPS: $-0.91
• 52-Week High: $3.78
• 52-Week Low: $1.27

Market Sentiment

Dare Bioscience Inc currently has a Bullish sentiment score of 0.18.

About Dare Bioscience Inc

Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on advancing women's health through the development of innovative therapeutics. The company is pioneering solutions that address significant unmet medical needs across various areas of women's health, leveraging a diverse pipeline of products poised for commercialization. By prioritizing the unique healthcare challenges faced by women, Dare aims to reshape the landscape of women's healt...

GNG Research Analysis

GNG Research scores Dare Bioscience Inc (DARE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DARE.

Frequently Asked Questions

Does DARE pay dividends?

Dare Bioscience Inc (DARE) does not currently pay a regular dividend.

What is DARE's market cap?

Dare Bioscience Inc (DARE) has a market capitalization of $32.81M with a current stock price of $2.14.